Parkinson's Disease Trial, Recruiting NCT07404241 Sponsor: University Hospital, Geneva Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07404241
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease using a specific standard set of diagnostic guidelines known as the UK Parkinson's Disease Society Brain Bank Criteria
  • People whose Parkinson's disease has reached a stage where their symptoms fluctuate — meaning their condition switches between periods of better and worse control (both movement-related and non-movement-related symptoms)
  • People who have been assessed before surgery and found to be a suitable candidate for a specific brain treatment called deep brain stimulation of the subthalamic nucleus (STN-DBS)
  • People who are currently taking medication that works on the dopamine system to manage their Parkinson's symptoms
  • People who have already had the STN-DBS device implanted between 4 and 8 weeks before the study measurements are taken

Who may not be able to join:

  • People who are older than 80 years of age
  • People who have dementia, identified by a score of 24 or below on a standard memory and thinking test called the MoCA
  • People who are currently experiencing active psychosis, or depression with thoughts of suicide
  • People who have another significant physical health condition that is not currently stable
  • People whose Parkinson's symptoms when off medication are so severe that they are unable to complete the study tasks — for example, severe painful muscle spasms or unbearable pain or anxiety (confirm with trial site)
  • People who are currently taking part in another trial involving a medication or drug
  • People who are not able to give their own informed consent to participate, such as those under legal guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41223722311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Geneva
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Correlation over-time of STN intracranial LFP activity and EEG resting-state oscillatory activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov